References
- Fang YJ, Wang GQ, Lu ZH, et al. (2012). Different effects of ERβ and TROP2 expression in Chinese patients with early-stage colon cancer. Tumour Biol 33:2227–35.
- Guerra E, Trerotola M, Aloisi AL, et al. (2013). The Trop-2 signalling network in cancer growth. Oncogene 32:1594–600.
- Kapoor S. (2013). TROP2 expression and its evolving role in tumor pathogenesis in systemic tumors. Tumour Biol 34:1967–8.
- Liang J, Qian Y, Xu D, et al. (2013). Serum tumor markers, hypoxia-inducible factor-lα(HIF-1α) and vascular endothelial growth factor, in patients with non-small cell lung cancer before and after intervention. Asian Pac J Cancer Prev 14:3851–4.
- Liu T, Liu YV, Bao XX, et al. (2013). Overexpression of TROP2 predicts poor prognosis of patients with cervical cancer and promotes the proliferation and invasion of cervical cancer cells by regulating ERK signaling pathway. PLoS One 8:e75864.
- McDougall AR, Tolcos M, Hooper SB, et al. (2015). Trop2: from development to disease. Dev Dyn 244:99–109.
- Nakashima K, Shimada H, Ochiai T, et al. (2004). Serological identification of TROP2 by recombinant cDNA expression cloning using sera of patients with esophageal squamous cell carcinoma. Int J Cancer 112:1029–35.
- Ning SL, Guo S, Xie JJ, et al. (2013). TROP2 correlates with microvessel density and poor prognosis in Hilar cholangiocarcinoma. J Gastrointest Surg 17:360–8.
- Shvartsur A, Bonavida B. (2015). Trop2 and its overexpression in cancers: regulation and clinical/therapeutic implications. Genes Cancer 6:84–105.
- Siegel R, Naishadham D, Jemal A. (2013). Cancer statistics, 2013. CA Cancer J Clin 63:11–30.
- Trerotola M, Cantanelli P, Guerra E, et al. (2013). Upregulation of Trop-2 quantitatively stimulates human cancer growth. Oncogene 32:222–33.